NeuroSense Therapeutics Ltd.(NASDAQ:NRSN) 
NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. Its lead product is PrimeC, an extended-release oral formulation of a fixed dose combination of ciprofloxacin an...
Website: https://www.neurosense-tx.com
Founded: 2017
Full Time Employees: 11
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 0.86
H 1.04
L 0.85
C 0.99
V 165,522
10EMA 0.99
20EMA 0.99
60EMA 0.99
120EMA 0.99
250EMA 0.99